PDS Biotechnology (FRA:EU6) E10: €-8.85 (As of Mar. 2026)


FRA:EU6 PDS Biotechnology Corp FRA:EU6
31 GF Score
Price €0.76
! 1 Warning Sign
View Full Analysis

What is PDS Biotechnology E10?

PDS Biotechnology FRA:EU6 -1.30% 31 E10 is €-8.85 as of Mar. 2026. GuruFocus rates FRA:EU6 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PDS Biotechnology's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.112. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-8.85 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), PDS Biotechnology's current stock price is €0.762. PDS Biotechnology's E10 for the quarter that ended in Mar. 2026 was €-8.85. PDS Biotechnology's Shiller PE Ratio of today is .


PDS Biotechnology  (FRA:EU6) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PDS Biotechnology E10 Related Terms


PDS Biotechnology E10 Historical Data

* Premium members only.

The historical data trend for PDS Biotechnology's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology E10 Chart

PDS Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -15.42 -10.69

PDS Biotechnology Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.30 -12.64 -11.04 -10.69 -8.85

FRA:EU6 vs INKT, PMVP, EDSA: E10 Comparison

For the Biotechnology subindustry, PDS Biotechnology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PDS Biotechnology Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PDS Biotechnology's Shiller PE Ratio falls into.


FRA:EU6
31GF Score
PDS Biotechnology Corp FRA:EU6
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PDS Biotechnology E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PDS Biotechnology's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.112/330.2130*330.2130
=-0.112

Current CPI (Mar. 2026) = 330.2130.

PDS Biotechnology Quarterly Data

per share eps CPI Adj_EPS
201606 -5.874 241.018 -8.048
201609 -6.593 241.428 -9.018
201612 -6.257 241.432 -8.558
201703 -7.854 243.801 -10.638
201706 -7.832 244.955 -10.558
201709 -6.209 246.819 -8.307
201712 -7.605 246.524 -10.187
201803 -0.195 249.554 -0.258
201806 -0.146 251.989 -0.191
201809 -0.180 252.439 -0.235
201812 -21.717 251.233 -28.544
201903 1.301 254.202 1.690
201906 -0.664 256.143 -0.856
201909 -0.999 256.759 -1.285
201912 -0.756 256.974 -0.971
202003 -0.353 258.115 -0.452
202006 -0.169 257.797 -0.216
202009 -0.178 260.280 -0.226
202012 -0.132 260.474 -0.167
202103 -0.118 264.877 -0.147
202106 -0.025 271.696 -0.030
202109 -0.204 274.310 -0.246
202112 -0.204 278.802 -0.242
202203 -0.291 287.504 -0.334
202206 -0.189 296.311 -0.211
202209 -0.263 296.808 -0.293
202212 -0.632 296.797 -0.703
202303 -0.299 301.836 -0.327
202306 -0.342 305.109 -0.370
202309 -0.328 307.789 -0.352
202312 -0.321 306.746 -0.346
202403 -0.276 312.332 -0.292
202406 -0.214 314.175 -0.225
202409 -0.261 315.301 -0.273
202412 -0.201 315.605 -0.210
202503 -0.194 319.799 -0.200
202506 -0.182 322.561 -0.186
202509 -0.162 324.800 -0.165
202512 -0.120 324.054 -0.122
202603 -0.112 330.213 -0.112

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-8.85 mean?
PDS Biotechnology (FRA:EU6) has a E10 of €-8.85 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PDS Biotechnology and its competitors.
Is PDS Biotechnology's E10 too high?
PDS Biotechnology's current E10 is €-8.85. Overall, PDS Biotechnology has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does PDS Biotechnology's E10 compare to INKT and PMVP?
PDS Biotechnology's E10 of €-8.85 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PDS Biotechnology and its competitors. PDS Biotechnology's current E10 is €-8.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PDS Biotechnology stock overvalued right now?
PDS Biotechnology (FRA:EU6) has a current E10 of €-8.85. The current E10 is €-8.85. PDS Biotechnology's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For PDS Biotechnology (FRA:EU6), the current E10 is €-8.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PDS Biotechnology Business Description

Other Exchanges PDSB:USA
Address 303A College Road, East Princeton, NJ, USA, 08540
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.
31GF Score

Get the complete analysis for FRA:EU6

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.76
Price